Foundations Counseling Center Llc | |
619 River St Ste F Belleville WI 53508-9117 | |
(608) 424-9100 | |
(608) 424-9099 |
Full Name | Foundations Counseling Center Llc |
---|---|
Speciality | Counselor - Mental Health |
Location | 619 River St Ste F, Belleville, Wisconsin |
Authorized Official Name and Position | Alisa Colleen Kelly-martina (EXECUTIVE CO-DIRECTOR) |
Authorized Official Contact | 6084249100 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Foundations Counseling Center Llc 619 River St Ste F Belleville WI 53508-9117 Ph: (608) 424-9100 | Foundations Counseling Center Llc 619 River St Ste F Belleville WI 53508-9117 Ph: (608) 424-9100 |
NPI Number | 1659579928 |
---|---|
Provider Enumeration Date | 07/06/2007 |
Last Update Date | 08/22/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1659579928 | NPI | - | NPPES |
42234600 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 2508 (Wisconsin) | Primary |
News Archive
A natural treatment for an antibiotic-resistant bacterial infection that causes blindness in infants can be effectively administered through a simple eye drop without causing irritation, Kingston University London researchers have found.
The first nurses in the country to finish a rigorous new nurse-midwifery program will receive their degrees today (May 14) from Dallas-based Baylor University Louise Herrington School of Nursing.
Interventional radiologists have devised a new way to access a woman's fibroids-by flipping her wrist and treating via an arm not groin artery-to nonsurgically shrink noncancerous growths in the muscular wall of the uterus. Researchers found this to be less painful and traumatic for women, allowing them to immediately sit up and move after uterine fibroid embolization (UFE)-with no overnight stay, according to a March article in the Society of Interventional Radiology's flagship publication, the Journal of Vascular and Interventional Radiology.
BIOFUEL ENERGY CORP., an ethanol production company, today announced its first quarter 2012 results.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
› Verified 2 days ago